메뉴 건너뛰기




Volumn 31, Issue 8, 2013, Pages 528-534

Executive summary. Management of influenza infection in solid-organ transplantrecipients: Consensus statement of the Group for the Study of Infection In Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases Andclinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)

Author keywords

Consensus; Influenza; Prophylaxis; Transplantation; Treatment; Vaccination

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

EID: 84893680215     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.01.014     Document Type: Article
Times cited : (7)

References (1)
  • 1
    • 84893680215 scopus 로고    scopus 로고
    • Management of influenza infection in solid-organ transplant recipients: Con-sensus statement of the group for the study of infection in transplant recipients(gesitra) of the spanish society of infectious diseases and clinical microbiol-ogy (seimc) and the spanish network for research in infectious diseases (reipi)
    • López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MA, Pérez-Romero P, et al. Management of influenza infection in solid-organ transplant recipients: con-sensus statement of the Group for the Study of Infection in Transplant Recipients(GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiol-ogy (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).Enferm Infecc Microbiol Clin. 2013;31:5261-720.
    • (2013) Enferm Infecc Microbiol Clin , vol.31 , pp. 5261-5720
    • López-Medrano, F.1    Cordero, E.2    Gavaldá, J.3    Cruzado, J.M.4    Marcos, M.A.5    Pérez-Romero, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.